Dr Olivier Tredan
- Spécialité
- Oncologue médical, expert sein et gynécologie
- Titre
- Coordinateur de département
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03. (1 févr. 2026)
- ESR1 mutation in Endocrine treatment naive Endometrial Cancer: Prevalence, Characteristics and Prognostic Implications, results from the UTOLA phase II GINECO trial. (8 janv. 2026)
- Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles. (12 déc. 2025)
- Effect of Breast Surgery on Quality of Life in BRCA Mutation Carriers With Invasive Breast Cancer: A CANTO Database Study. (1 déc. 2025)
- Reply to: Critical evaluation of the ProfiLER-02 study design and outcomes. (1 oct. 2025)